NASDAQ:XERS | EBITDA | Xeris Biopharma Holdings, Inc.

Complete source-backed ebitda history.

Available history
2020-12-31 to 2026-03-31
Data captured

Historical EBITDA

DateEBITDA
2026-03-31$8.25M
2025-12-31$17.11M
2025-03-31-$2.78M
2024-12-31$1.99M
2024-03-31-$13.92M
2023-12-31-$9.5M
2023-03-31-$12.91M
2022-12-31-$14.8M
2022-03-31-$28.75M
2021-12-31-$47.92M
2021-03-31-$16.4M
2020-12-31-$18.9M

Annual EBITDA

DateEBITDA
2025-12-31$26.21M
2024-12-31-$32.42M
2023-12-31-$42.52M
2022-12-31-$80.54M
2021-12-31-$113.83M
2020-12-31-$82.08M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.